Will the Party Continue for Canopy Growth Corp.?

Shares of Canopy Growth Corp. (TSX:CGC) have been on a tear as of late. Will it continue?

| More on:

On Monday this week, Canopy Growth Corp. (TSX:CGC) reported earnings, exceeding estimates and reporting a profit of $5.4 million on revenues of $8.5 million. In response to the news, shares rose by 19.5% to $11.16 per share. Clearly, it was a good day for investors.

Looking at the past few months for the company, investors have had a great time holding the stock. Since September, the stock is up almost 250%. What a party!

But there’s a lot more to it than just the earnings and revenues. In the past five quarters, revenues have increased from $2.466 million to $8.498 million–an increase of 245% in only five quarters. What makes this story even more scintillating is the increase in clients, or patients, as the company refers to them. The total number of clients increased from 6,272 to 24,477 in the same period–an increase of 290%.

What we learn from the increase in total clients vs. the increase in revenue is that new clients are buying just a little less product than the older clients. Although the increase in clientele is a good thing, it is not what blew the results out of the water.

In the past quarter it was announced the company had a gain in their assets of $16.1 million, reflecting the strong expectation of continued demand for the product offered by the company. Basically, the outlook is fantastic going into the future. Offering medical marijuana, the company is currently the biggest player in a high-growth market.

As of right now, marijuana in Canada is only available for those needing it for medical purposes, but with a return of almost 250% in only a few months, investors may be pricing in greater sales or clientele than is realistic. At the current price of $11.16, the legalization of marijuana may be priced into the security.

Uniquely positioned as Canada’s dominant competitor, the company could reap huge benefits from sale of marijuana to anyone wanting to buy it. The risk in this case, however, is the chance the government doesn’t legalize the product and the market remains the medical-treatment field only.

Canopy doesn’t currently pay a dividend, so the return for investors will come in the form of capital gains only. At this time, although a net profit has been recorded, it is not because of an inflow of cash. The net profit recorded was due to an increase in the value of the company’s assets.

For existing investors, the party has been a really good time, leading them to play with house money. For anyone looking at a new point of entry into the stock, it may be best to be cautious.

Because we aren’t sure if the fun times are behind us or still ahead, this stock will be one to watch for a long time.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Goldsman has no position in any stocks mentioned.

More on Investing

Financial technology concept.
Bank Stocks

How Much Will Royal Bank of Canada Pay in Dividends This Year?

Royal Bank offers safe dividends. However, it would be safer for investors to buy on a pullback.

Read more »

alcohol
Stocks for Beginners

4 Stocks That Can Help You to Get Richer in 2024

Looking for stocks that could help you get richer in 2024 and long into the future. These four stocks have…

Read more »

Overhead shot of young adults using technology at a table
Tech Stocks

Missed Out on Nvidia Stock? Buy Celestica Stock Instead

Nvidia stock (NASDAQ:NVDA) has certainly been the heavy hitter of 2023 and 2024, but this stock has grown even more…

Read more »

little girl in pilot costume playing and dreaming of flying over the sky
Investing

Bombardier Is Up 16.9% Percent After Earnings: What Investors Need to Know

The recent stock upgrade and multiple growth levers are compelling reasons to invest in Bombardier in 2024.

Read more »

edit Balloon shaped as a heart
Dividend Stocks

2 Dirt-Cheap Retail Stocks Fit for Dividend Lovers

Metro (TSX:MRU) and another great retailer that could be ripe for buying in May 2024 for the next three years.

Read more »

railroad
Dividend Stocks

Bull Market Buys: 1 Magnificent Stock to Own for the Long Run

This one cyclical stock could be the best long-term option for investors, especially while shares still offer a steal of…

Read more »

healthcare pharma
Stocks for Beginners

These 2 Healthcare Stocks Are Set to Soar in 2024 and Beyond 

Are you looking for innovation and growth? These two healthcare stocks offer exposure to the growing tech of the healthcare…

Read more »

A small flower grows out of a concrete crack.
Tech Stocks

Is Nvidia the Next Stock Split?

Nvidia (NASDAQ:NVDA) may announce a stock split ahead of Constellation Software (TSX:CSU) stock. Here why you should care.

Read more »